One-year initial efficacy and safety outcomes of the premounted dry-pericardium Vienna self-expandable transcatheter aortic valve system: A first-in-human VIVA feasibility study.
Kasparas BriedisEgle RumbinaiteAli AldujeliKamilija BriedeMartynas JurenasPovilas JakuskaAntanas JankauskasIndre CeponieneTadas LenkutisJurgita PlisieneRimantas BenetisRemigijus ZaliunasPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2024)
The study indicates the Vienna valve as a potential option for severe symptomatic aortic stenosis, designed to streamline the procedure and potentially lower healthcare costs by reducing resource and equipment needs, also procedural errors. Further research is essential to thoroughly evaluate its safety and efficacy.
Keyphrases
- aortic valve
- aortic stenosis
- transcatheter aortic valve replacement
- aortic valve replacement
- transcatheter aortic valve implantation
- ejection fraction
- healthcare
- endothelial cells
- left ventricular
- coronary artery disease
- minimally invasive
- early onset
- patient safety
- metabolic syndrome
- adipose tissue
- induced pluripotent stem cells
- emergency department
- insulin resistance